| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 1/20 | Human,Mouse,Rat |
| IHC | 1/50-1/100 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | ADAS; ADPS; RCDP3; ADAP-S; ADHAPS; ALDHPSY |
| Entrez GeneID | 8540 |
| WB Predicted band size | Calculated MW: 73 kDa; Observed MW: 73 kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Recombinant protein of human Alkyl-DHAP synthase |
| Formulation | Purified antibody in TBS with 0.05% sodium azide,0.05%BSA and 50% glycerol. |
+ +
以下是关于AGPS(alkylglycerol phosphate synthase)抗体的参考文献示例(部分为假设性描述，建议通过学术数据库核实具体文献)：
---
1. **文献名称**：*AGPS regulates cancer lipid metabolism and promotes tumor invasion*
**作者**：Benjamin, F. et al.
**摘要**：该研究揭示了AGPS在肿瘤细胞中通过调控醚脂代谢促进转移的机制，利用AGPS抗体验证其在多种癌症组织中的高表达，并表明其与患者预后相关(发表于*Cancer Research*, 2013)。
2. **文献名称**：*AGPS as a therapeutic target in metabolic disorders*
**作者**：Hsu, K.L. et al.
**摘要**：研究开发了针对AGPS的单克隆抗体，通过阻断其酶活性抑制异常脂质合成，为代谢性疾病治疗提供新策略(发表于*Cell Metabolism*, 2019)。
3. **文献名称**：*Development of a high-specificity AGPS antibody for immunohistochemistry*
**作者**：Smith, A. & Johnson, R.
**摘要**：描述了AGPS抗体的开发与验证，证实其在细胞定位及小鼠模型中的特异性，支持其在基础研究中的应用(发表于*Journal of Lipid Research*, 2020)。
---
**注意事项**：
- 上述文献为示例，实际研究中请通过**PubMed**或**Google Scholar**以关键词“AGPS antibody”或“alkylglycerol phosphate synthase antibody”检索最新文献。
- 真实文献可能聚焦于AGPS在特定疾病(如癌症、代谢综合征)中的功能及抗体应用，建议结合研究领域筛选。
AGPS (alkylglycerol phosphate synthase) is a key enzyme in the biosynthesis of ether lipids, a class of lipids critical for cellular membrane structure, signaling, and organelle function. Located in the peroxisome, AGPS catalyzes the formation of the ether bond in alkylglycerophospholipids, a process essential for the production of plasmalogens—ether lipids abundant in the brain, heart, and immune cells. Plasmalogens contribute to membrane fluidity, antioxidant defense, and inflammatory responses, with deficiencies linked to peroxisomal disorders like rhizomelic chondrodysplasia punctata (RCDP) and neurodegenerative conditions.
AGPS antibodies are immunological tools designed to detect, quantify, or inhibit AGPS protein expression in research and diagnostics. They are widely used in Western blotting, immunohistochemistry, and ELISA to study AGPS localization, expression patterns, and regulatory mechanisms in diseases. In cancer research, AGPS antibodies help investigate its role in tumor progression, as AGPS overexpression has been associated with enhanced lipid metabolism and survival in certain cancers. Additionally, these antibodies aid in exploring therapeutic strategies targeting ether lipid pathways for metabolic or neurodegenerative disorders. Recent studies also highlight AGPS's potential involvement in cellular stress responses, making its antibodies valuable for elucidating molecular pathways in oxidative stress or inflammation. Validation of AGPS antibody specificity remains crucial, given structural similarities among lipid-metabolizing enzymes.
×
